White label ELPA - ClinicalTrials.eu

Study on the Effects of Tasipimidine for Patients with Insomnia Disorder

Not recruiting

2 1
Investigated diseases:
- Insomnia
Investigated drugs:
- Tasipimidine
Study of BMS-986408 Alone or with Nivolumab and Ipilimumab for Patients with Advanced Solid Tumors

Not recruiting

2 1 1 1
Investigated diseases:
- Neoplasm
Investigated drugs:
Study on Giredestrant or Tamoxifen for Premenopausal Women with Early ER-Positive, HER2-Negative Breast Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Hormone receptor positive HER2 negative breast cancer
Investigated drugs:
- Giredestrant
- Tamoxifen
Long-Term Follow-Up Study of Imlifidase in Highly Sensitized Kidney Transplant Patients

Not recruiting

3 1 1 1
Investigated diseases:
- Kidney transplant rejection
Investigated drugs:
- Imlifidase
+2
Study on Everolimus and Mycophenolate Mofetil for Improving COVID-19 Vaccine Response in Kidney Transplant Patients

Not recruiting

3 1 1 1
Investigated diseases:
Investigated drugs:
Study on Teicoplanin Dosing for Patients with Sepsis: Comparing TDM-Optimized Dosing to Standard Care

Not recruiting

3 1 1 1
Investigated diseases:
- Sepsis
Investigated drugs:
- Teicoplanin
Study on BIA 28-6156 for Parkinson’s Disease in Patients with GBA1 Gene Variant

Not recruiting

2 1
Investigated diseases:
- Parkinson’s disease
Investigated drugs:
- 5,7-Dimethyl-N-((1R,4R)-4-(Pentyloxy)Cyclohexyl)Pyrazolo[1,5-A]Pyrimidine-3-Carboxamide
+2
Study on Long-Term Safety of Eplontersen for Adults with Transthyretin-Mediated Amyloid Cardiomyopathy

Not recruiting

3 1 1 1
Investigated diseases:
- Cardiac amyloidosis
Investigated drugs:
+6
Study on the Safety and Effectiveness of THE-630 for Patients with Advanced Gastrointestinal Stromal Tumors (GIST)

Not recruiting

2 1 1
Investigated drugs:
- The-630
Study on the Effects of Ecopipam Hydrochloride for Children and Adolescents with Tourette’s Disorder

Not recruiting

3 1
Investigated diseases:
- Tourette’s disorder
Investigated drugs:
- Ecopipam Hydrochloride
+3

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies